ROKIT Healthcare Inc.
Research ROKIT Healthcare Inc. (376900.KQ) on Bullrun: market cap KRW 336.36B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker376900.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyKRW
- Market capKRW 336.36B
- Financial periodQ2 2026
- RevenueKRW 8.22B
- Net income-KRW 9.34B
- Free cash flow-KRW 9.12B
- Gross margin21.1%
Valuation Snapshot
latest market cap is KRW 336.36B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 336.36B | n/a | n/a | n/a |
Dividend history
About ROKIT Healthcare Inc.
ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ROKIT Healthcare Inc.'s market cap?
ROKIT Healthcare Inc.'s market capitalization is KRW 336.36B.
What does ROKIT Healthcare Inc. do?
ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD).